Frauen und Arrhythmien

In den letzten Jahren wurde zunehmend erkannt: Bei der Inzidenz und Ätiologie von Herzrhythmusstörungen gibt es große geschlechtsspezifische Unterschiede – oft auch beim Therapieansprechen und dem Zugang zu einer Therapie. Dieser Beitrag zeigt, wie die geschlechtsbedingt unterschiedliche Ätiologie und Pathophysiologie bestimmter Herzrhythmusstörungen letztlich zu frauenspezifischen Behandlungsstrategien führen können.

Schlüsselwörter

Herzrhythmusstörungen - geschlechtsspezifische Unterschiede - Vorhofflimmern - Ionenkanalerkrankungen - Tachykardien

• Literatur

• 1 Linde C, Bongiorni MG, Birgersdotter-Green U. et al. ESC Scientific Document Group. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Europace 2018; 20: 1565a-1565ao doi:10.1093/europace/euy067
• 2 Gaborit N, Varro A, Le Bouter S. et al. Gender related differences in ion-channel and transporter subunit expression in non-diseased human hearts. J Mol Cell Cardiol 2010; 49: 639-646
• 3 Rautaharju PM, Zhou SH, Wong S. et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992; 8: 690-695
• 4 Priori SG, Blomstrom-Lundqvist C, Mazzanti A. et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015; 36: 2793-2867
• 5 Corrado D, Wichter T, Link MS. et al. Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: An international task force consensus statement. Eur Heart J 2015; 36: 3227-3237
• 6 Bogle BM, Ning H, Mehrotra S. et al. Lifetime risk for sudden cardiac death in the community. J Am Heart Assoc 2016; 5: e002398
• 7 Stecker EC, Reiner K, Marijon E. et al. Public health burden of sudden cardiac death in the United States. Circ Arrhythm Electrophysiol 2014; 7: 212-217
• 8 Blom MT, Oving I, Berdowski J. et al. Women have lower chances than men to be resuscitated and survive out-of-hospital cardiac arrest. Eur Heart J 2019; 40: 3824-3834 doi:10.1093/eurheartj/ehz297
• 9 Albert C, McGovern BA, Newell JB. et al. Sex differences in cardiac arrest survivors. Circulation 1996; 93: 1170-1176
• 10 Nakagawa M, Takahashi N, Nobe S. et al. Gender differences in various types of idiopathic ventricular tachycardia. J Cardiovasc Electrophysiol 2002; 13: 633-638
• 11 Marchilinski FE, Haffajee CI, Beshai JF. et al. Long-term success of irrigated radiofrequency catheter ablation of sustained ventricular tachycardia. Post-approval Thermocool VT Trial. J Am Coll Cardiol 2016; 67: 674-683
• 12 Sapp JL, Wells GA, Parkash R. et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med 2016; 375: 111-121
• 13 Frankel DS, Tung R, Santangeli P. et al. Sex and catheter ablation for ventricular tachycardia. JAMA Cardiol 2016; 1: 938-944
• 14 Baldinger SH, Kumar S, Romero J. et al. A comparison of women and men undergoing catheter ablation for sustained monomorphic ventricular tachycardia. J Cardiovasc Electrophysiol 2017; 28: 201-207
• 15 Tadros R, Ton AT, Fiset C. et al. Sex differences in cardiac electrophysiology and clinical arrhythmias: epidemiology, therapeutics, and mechanisms. Can J Cardiol 2014; 30: 783-792
• 16 Rosano GMC, Leonardo F, Sarrel PM. et al. Cyclical variation in paroxysmal supraventricular tachycardia in women. Lancet 1996; 347: 786-788
• 17 Farkowski MM, Pytkowski M, Maciag A. et al. Gender-related differences in outcomes and resource utilization in patients undergoing radiofrequency ablation of supraventricular tachycardia: results from Patientsʼ Perspective on Radiofrequency Catheter Ablation of AVRT and AVNRT Study. Europace 2014; 16: 1821-1827
• 18 Wood KA, Wiener CL, Kayser-Jones J. Supraventricular tachycardia and the struggle to be believed. Eur J Cardiovasc Nurs 2007; 6: 293-302
• 19 Lip GY, Laroche C, Boriani G. et al. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace 2015; 17: 24-31
• 20 Kirchhof P, Benussi S, Kotecha D. et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Europace 2016; 18: 1609-1678
• 21 Sullivan RM, Zhang J, Zamba G. et al. Relation of gender specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM). Am J Cardiol 2012; 110: 1799-1802
• 22 Ruff CT, Giugliano RP, Braunwald E. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 2014; 383: 955-962
• 23 Piccini JP, Simon DN, Steinberg BA. et al. Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF Registry. JAMA Cardiol 2016; 1: 282-291
• 24 Rienstra M, Van Veldhuisen DJ, Hagens VE. et al. Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study. J Am Coll Cardiol 2005; 46: 1298-1306
• 25 Patel N, Deshmukh A, Thakkar B. et al. Gender, race, and health insurance status in patients undergoing catheter ablation for atrial fibrillation. Am J Cardiol 2016; 117: 1117-1126
• 26 Zylla MM, Brachmann J, Lewalter T. et al. Sex-related outcome of atrial fibrillation ablation: Insights from the German Ablation Registry. Heart Rhythm 2016; 13: 1837-1844
• 27 Verma A, Jiang CY, Betts TR. et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015; 372: 1812-1822
• 28 Gadler F, Valzania C, Linde C. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverterdefibrillator registry. Europace 2015; 17: 69-77
• 29 Kirkfeldt RE, Johansen JB, Nohr EA. et al. Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark. Eur Heart J 2014; 35: 1186-1194
• 30 Sticherling C, Arendacka B, Svendsen JH. et al. Sex differences in outcomes of primary prevention implantable cardioverter defibrillator therapy: combined registry data from eleven European countries. Europace 2018; 20: 963-970 doi:10.1093/europace/eux176
• 31 Linde C, Cleland J, Gold MR. et al. The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis. Results from a case based meta-analysis. Eur J Heart Fail 2018; 20: 780-791 doi:10.1002/ejhf.1133
• 32 Bongiorni MG, Kennergren C, Butter C. et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes. Eur Heart J 2017; 38: 2995-3005